BioLineRx (BLRX) – Litigation
-
BioLineRx (BLRX) Announces Notice of Allowance from USPTO Covering Motixafortide in Combination With Anti-PD-1 for Treatment of Any Type of Cancer
-
BioLineRx (BLRX) Announces Notice of Allowance From USPTO for Patent Covering AGI-134
-
-
-
-
-
-
-
-
-
Back to BLRX Stock Lookup